Bayer Partnering Day
Bayer HealthCare, one of the top 10 diversified healthcare companies, is actively seeking collaborative drug discovery partnerships with U.S. life sciences firms and research institutions to advance new medicines to patients. Bayer Partnering Day is an exclusive event that is designed to connect companies with high quality therapeutic and technology projects with Bayer for potential collaboration discussions.
Why Partner with Bayer HealthCare?
Bayer HealthCare has a long and successful track record in advancing partnered projects from the research bench to patients and physicians around the world. With sales greater than ‚Ç¨10 Billion in 2009, Bayer is the 12th largest global pharmaceutical company, and among the top 10 biotechnology firms.
Bayer’s strong commitment to collaboration is evidenced by the fact that one third of Bayer’s research and development portfolio is collaborative projects. Leading marketed products such as Nexavar¬Æ demonstrate Bayer’s ability to bring scientific, clinical development and global commercial expertise to any project. The company seeks to work with life science firms who have made novel discoveries by bringing the depth of Bayer’s technical expertise in core scientific and therapeutic areas to partnered projects. Examples of our collaborations include our work with OncoMed to explore novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway and with Regeneron to develop Eylea¬Æ for the treatment of eye disease.
|What:||Bayer Partnering Day|
|When:||Tuesday, March 29, 2011
8:00am – 10:00am: Breakfast Plenary
10:00m – 4:30pm: One-on-One Partnering Meetings
4:30pm – 6:30pm: Closing Reception
400 Oyster Point Blvd., Suite 221
South San Francisco, CA 94080
View Map and driving directions
Participation is Open to
|Attire:||Business attire suggested|